ELDN
Eledon Pharmaceuticals Inc
NASDAQ: ELDN · HEALTHCARE · BIOTECHNOLOGY
$3.64
+8.98% today
Updated 2026-04-30
Market cap
$275.92M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$1 – $5
Volume
1.5M
Eledon Pharmaceuticals Inc (ELDN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $120000.00 | $120000.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | +0.0% | -100.0% | — | — | — |
| Cost of revenue | — | — | $58.00 | $109000.00 | $35000.00 | $22000.00 | $11000.00 | $182000.00 | $183000.00 | $195000.00 | $373000.00 | $374000.00 | $359000.00 | — |
| Gross profit | — | — | $-58.00 | $-109000.00 | $-35000.00 | $-22000.00 | $-11000.00 | $-182000.00 | $-183000.00 | $120000.00 | $-373000.00 | $-374000.00 | $-359000.00 | — |
| Gross margin | — | — | — | — | — | — | — | — | -152.5% | 100.0% | — | — | — | — |
| R&D | $7.37M | $12.20M | $14.58M | $32.64M | $25.02M | $2.02M | $6.82M | $8.13M | $6.13M | $23.73M | $27.08M | $30.31M | $51.96M | $66.27M |
| SG&A | $2.28M | $3.55M | $8.88M | $12.62M | $13.10M | $11.10M | $7.24M | $6.06M | $10.05M | $13.13M | $12.70M | $12.69M | $18.61M | $16.98M |
| Operating income | $-9.65M | $-15.75M | $-23.46M | $-45.26M | $-38.12M | $-13.12M | $-14.06M | $-14.18M | $-13.28M | $-36.87M | $-39.78M | $-43.00M | $-70.58M | $-83.25M |
| Operating margin | — | — | — | — | — | — | — | — | -11069.2% | -30722.5% | — | — | — | — |
| EBITDA | $-9.64M | $-15.71M | $-23.27M | $-44.98M | $-6.90M | $-13.10M | $-14.05M | $-15.83M | $-23.03M | $-36.67M | $-87.59M | $-42.63M | $-35.39M | $-83.25M |
| EBITDA margin | — | — | — | — | — | — | — | — | -19193.3% | -30560.0% | — | — | — | — |
| EBIT | $-9.65M | $-15.72M | $-23.30M | $-45.09M | $-6.93M | $-13.12M | $-14.06M | $-16.01M | $-23.21M | $-36.87M | $-87.97M | $-43.00M | $-35.75M | — |
| Interest expense | $0.00 | $0.00 | $0.00 | $174000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $9.31M | $202000.00 | $462000.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-9.65M | $-15.72M | $-23.30M | $-45.09M | $-37.96M | $-13.12M | $-14.06M | $-16.01M | $-22.81M | $-34.51M | $-87.97M | $-40.33M | $-36.18M | $-45.62M |
| Net income growth (YoY) | — | -63.0% | -48.1% | -93.5% | +15.8% | +65.4% | -7.2% | -13.8% | -42.5% | -51.3% | -154.9% | +54.2% | +10.3% | -26.1% |
| Profit margin | — | — | — | — | — | — | — | — | -19009.2% | -28755.0% | — | — | — | — |